Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 1
2010 5
2011 2
2012 1
2013 2
2014 4
2015 6
2016 3
2017 8
2018 4
2019 8
2020 7
2021 5
2022 11
2023 8
2024 8
2025 14
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Pregabalin.
Cross AL, Viswanath O, Sherman AL. Cross AL, et al. 2024 May 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 May 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 29261857 Free Books & Documents.
Off-label applications include generalized anxiety disorder, social anxiety disorder, bipolar disorder, insomnia, and chronic pain conditions not sanctioned by the FDA. This activity prioritizes understanding pregabalin's mechanism of action, adverse e
Off-label applications include generalized anxiety disorder, social anxiety disorder, bipolar disorder, insomnia, and chronic
Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale.
Hong JSW, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A. Hong JSW, et al. Mol Psychiatry. 2022 Mar;27(3):1339-1349. doi: 10.1038/s41380-021-01386-6. Epub 2021 Nov 24. Mol Psychiatry. 2022. PMID: 34819636 Free PMC article.
Many of these uses are off-label for psychiatric indications, and there is increasing concern about their safety, so it is particularly important to have good evidence to justify this usage. ...Fifty-five double-blind randomised controlled trials (RCTs) and 15 open- …
Many of these uses are off-label for psychiatric indications, and there is increasing concern about their safety, so it is par …
Ongoing challenges of off-label prescribing.
Day RO. Day RO. Aust Prescr. 2023 Dec;46(4):86-89. doi: 10.18773/austprescr.2023.022. Aust Prescr. 2023. PMID: 38152320 Free PMC article. Review.
There may be additional costs to the patient if the medicine is not subsidised for the off-label indication. Prescribers should ensure patients are aware when a medicine is being prescribed off label, and informed of potential benefits and harms. Alter …
There may be additional costs to the patient if the medicine is not subsidised for the off-label indication. Prescribers shoul …
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.
Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Garakani A, et al. Front Psychiatry. 2020 Dec 23;11:595584. doi: 10.3389/fpsyt.2020.595584. eCollection 2020. Front Psychiatry. 2020. PMID: 33424664 Free PMC article. Review.
This review's first aim is to summarize current pharmacological treatments (both approved and off-label) for panic disorder (PD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and specific phobias (SP), including selective serotonin reuptake inh …
This review's first aim is to summarize current pharmacological treatments (both approved and off-label) for panic disorder (P …
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery.
Atkin T, Comai S, Gobbi G. Atkin T, et al. Pharmacol Rev. 2018 Apr;70(2):197-245. doi: 10.1124/pr.117.014381. Pharmacol Rev. 2018. PMID: 29487083 Review.
Although the GABAergic benzodiazepines (BZDs) and Z-drugs (zolpidem, zopiclone, and zaleplon) are FDA-approved for insomnia disorders with a strong evidence base, they have many side effects, including cognitive impairment, tolerance, rebound insomnia upon discontinuation, car ac …
Although the GABAergic benzodiazepines (BZDs) and Z-drugs (zolpidem, zopiclone, and zaleplon) are FDA-approved for insomnia disorders with a …
Prescription of Controlled Substances: Benefits and Risks.
Preuss CV, Kalava A, King KC. Preuss CV, et al. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
For pain lasting more than 1 week, the extended-release form is preferred, as it is indicated for pain control under 24-hour management or an extended period. Tramadol has demonstrated off-label effectiveness in the management of premature ejaculation and restless l …
For pain lasting more than 1 week, the extended-release form is preferred, as it is indicated for pain control under 24-hour management or a …
"Fibromyalgia - are there any new approaches?".
Martinez JE, Guimarães I. Martinez JE, et al. Best Pract Res Clin Rheumatol. 2024 Mar;38(1):101933. doi: 10.1016/j.berh.2024.101933. Epub 2024 Feb 13. Best Pract Res Clin Rheumatol. 2024. PMID: 38355316 Review.
Medications approved by Food and Drug Administration are duloxetine, milnacipran and pregabalin. Amitriptyline, cyclobenzaprine, gabapentin and naltrexone are considered for off-label use. ...
Medications approved by Food and Drug Administration are duloxetine, milnacipran and pregabalin. Amitriptyline, cyclobenzaprine, gaba …
Comparison of Amitriptyline and US Food and Drug Administration-Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis.
Farag HM, Yunusa I, Goswami H, Sultan I, Doucette JA, Eguale T. Farag HM, et al. JAMA Netw Open. 2022 May 2;5(5):e2212939. doi: 10.1001/jamanetworkopen.2022.12939. JAMA Netw Open. 2022. PMID: 35587348 Free PMC article.
IMPORTANCE: Amitriptyline is an established medication used off-label for the treatment of fibromyalgia, but pregabalin, duloxetine, and milnacipran are the only pharmacological agents approved by the US Food and Drug Administration (FDA) to treat fibromyalgi …
IMPORTANCE: Amitriptyline is an established medication used off-label for the treatment of fibromyalgia, but pregabalin
A Clinical Overview of Off-label Use of Gabapentinoid Drugs.
Goodman CW, Brett AS. Goodman CW, et al. JAMA Intern Med. 2019 May 1;179(5):695-701. doi: 10.1001/jamainternmed.2019.0086. JAMA Intern Med. 2019. PMID: 30907944 Review.
OBSERVATIONS: This report summarizes the limited published evidence to support off-label gabapentinoid uses, describes clinical cases in which off-label use is problematic, and notes how review articles and guidelines tend to overstate gabapenti …
OBSERVATIONS: This report summarizes the limited published evidence to support off-label gabapentinoid uses, describes clinica …
91 results